The belief that surgery spreads cancer is a common public misconception. Onco-surgeon Yogeshwar Shukla spoke to Free Press on cancer treatment and misconceptions. Excerpts: There is a perception that ...
Mumbai: India is facing a silent cancer crisis, with nearly 60% to 80% of cases being diagnosed only at advanced stages, drastically reducing survival chances. With over 15 lakh new cases reported ...
Amanda Peet writes, “I admire people who can sit with uncertainty in matters of life and death. I’m not one of them. I suck ...
A bacterium associated with gum disease may contribute to the development and spread of breast cancer. Scientists have found that the microorganism is able to penetrate breast tissue through the ...
Your mouth can reveal early signs of serious diseases like diabetes, anemia, vitamin B12 deficiency, acid reflux, HIV, oral ...
Talquetamab delivers high response rates in refractory myeloma; learn how to prevent skin, nail and oral side effects to stay on therapy. As the therapeutic arsenal for relapsed/refractory multiple ...
A surprising link between oral health and breast cancer has been revealed in a new study. Researchers have discovered that a common bacterium associated with gum disease can enter the bloodstream and ...
Asianet Newsable on MSN
World Oral Health Day 2026: Early signs of oral cancer you should never ignore
Cases of Oral Cancer are rising in India. On World Oral Health Day, experts urge people to recognise early warning signs for timely diagnosis and better treatment outcomes.
A common oral bacterium tied to gum disease may help spark and fuel breast cancer, according to new research. Scientists discovered it can travel through the bloodstream to breast tissue, where it ...
Verastem (VSTM) stock receives a "Buy" rating, driven by progress in KRAS G12D-targeted therapies and multiple 2026 catalysts. Read the full analysis here.
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel ...
Equity-Insider.com News Commentary -- Big money is moving back into biotech. Institutional investors have been writing some of the largest checks in years, with major financing rounds already closing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results